Effect of α-lactalbumin and β-lactoglobulin hydrolysates on markers of metabolic syndrome
dc.contributor.author | Lagace, Melissa | |
dc.contributor.examiningcommittee | Scanlon, Martin (Food Science) Aluko, Rotimi (Human Nutritional Sciences) | en_US |
dc.contributor.supervisor | Arntfield, Susan (Food Science) Rempel, Curtis (Food Science) | en_US |
dc.date.accessioned | 2012-09-07T14:32:17Z | |
dc.date.available | 2012-09-07T14:32:17Z | |
dc.date.issued | 2012-09-07 | |
dc.degree.discipline | Food Science | en_US |
dc.degree.level | Master of Science (M.Sc.) | en_US |
dc.description.abstract | The effects of peptides derived from β-lactoglobulin and α-lactalbumin on metabolic syndrome were studied. α-lactalbumin and β-lactoglobulin were hydrolyzed with trypsin, alcalase, flavourzyme, or a combination of alcalase and flavourzyme and fractionated. Angiotensin coverting enzyme inhibition of the < 1 kDa fraction of alcalase hydrolyzed β-lactoglobulin was 95 %. Antioxidant activity of the < 1 kDa fraction of β-lactoglobulin hydrolyzed with a combination of alcalase and flavourzyme was 18 %. Stimulated adipocytes incubated with the < 1 kDa fraction of β-lactoglobulin hydrolyzed with either trypsin or alcalase produced 30 pg/mL of interleukin 6. Adiponectin and glucose transporter type 4 secretions increased 1.1 and 0.86 fold respectively during incubation with the < 1 kDa fraction of β-lactoglobulin hydrolyzed with a combination of alcalase and flavourzyme. Results indicate that β-lactoglobulin peptides formed with alcalase and a combination of alcalase and flavourzyme influence markers associated with metabolic syndrome and may be useful as functional foods or nutraceuticals. | en_US |
dc.description.note | October 2012 | en_US |
dc.identifier.uri | http://hdl.handle.net/1993/8617 | |
dc.language.iso | eng | en_US |
dc.rights | open access | en_US |
dc.subject | metabolic | en_US |
dc.subject | whey | en_US |
dc.subject | inflammation | en_US |
dc.subject | hypertension | en_US |
dc.subject | diabetes | en_US |
dc.subject | hydrolysis | en_US |
dc.subject | syndrome | en_US |
dc.subject | lactalbumin | en_US |
dc.subject | lactoglobulin | en_US |
dc.subject | interleukin | en_US |
dc.subject | adipocyte | en_US |
dc.subject | macrophage | en_US |
dc.subject | glucose | en_US |
dc.subject | adiponectin | en_US |
dc.subject | alcalase | en_US |
dc.subject | flavourzyme | en_US |
dc.subject | trypsin | en_US |
dc.subject | oryzae | en_US |
dc.subject | lichenformis | en_US |
dc.subject | peptide | en_US |
dc.title | Effect of α-lactalbumin and β-lactoglobulin hydrolysates on markers of metabolic syndrome | en_US |
dc.type | master thesis | en_US |